Treatment with semaglutide improved maximum walking distance in patients with type 2 diabetes (T2D) and symptomatic peripheral artery disease (PAD), according to results from the STRIDE trial ...
The Trump administration canceled a Biden-era plan on Friday that would have made Ozempic and other weight-loss drugs ...